Bong Tiffany S H, Aw Darius K L, Cheng Shin Chuen, Choke Edward T C, Tay Jia Sheng
Department of Surgery, Sengkang General Hospital, Singapore.
J Endovasc Ther. 2023 Jun;30(3):401-409. doi: 10.1177/15266028221083222. Epub 2022 Mar 11.
This study aims to describe an efficacious method using Cleaner XT rotational thrombectomy with catheter-directed thrombolysis and drug-eluting balloon angioplasty for the salvage of thrombosed arteriovenous fistulae and grafts.
Retrospective analysis of all patients with thrombosed hemodialysis accesses who underwent endovascular salvage using the Cleaner XT rotational thrombectomy system at a single institution between June 2019 and September 2020 was performed. Patency was presented as Kaplan-Meier survival curves, and regression analysis was performed to examine predictors of postintervention primary patency and assisted primary patency based on Cox proportional-hazards model.
Thirty-four patients with thrombosed accesses underwent Cleaner XT rotational thrombectomy between June 2019 and September 2020. Technical and clinical success were both 100%. Mean procedure time was 62 ± 20 minutes. Mean postintervention primary patency time was 152 ± 51 days; 30, 90, 180, and 365 day postintervention primary patency rates were 89%, 80%, 68%, and 56%, respectively. Mean postintervention-assisted primary patency time was 157 ± 59 days; 30, 90, 180, and 365 day postintervention-assisted primary patency rates were 91%, 82%, 71%, and 59%, and 180 and 365 day secondary patency rates were 97.2% and 94.4%, respectively.
The Cleaner XT rotational thrombectomy device demonstrates excellent clinical and technical success rates, with good patency results at all time points up to 12 months postintervention.
本研究旨在描述一种有效的方法,即使用Cleaner XT旋转血栓切除术联合导管定向溶栓及药物洗脱球囊血管成形术来挽救血栓形成的动静脉内瘘和移植物。
对2019年6月至2020年9月期间在单一机构接受使用Cleaner XT旋转血栓切除术系统进行血管腔内挽救治疗的所有血栓形成的血液透析通路患者进行回顾性分析。通畅率以Kaplan-Meier生存曲线表示,并基于Cox比例风险模型进行回归分析,以检查干预后原发性通畅和辅助原发性通畅的预测因素。
2019年6月至2020年9月期间,34例血栓形成的通路患者接受了Cleaner XT旋转血栓切除术。技术成功率和临床成功率均为100%。平均手术时间为62±20分钟。干预后原发性通畅的平均时间为152±51天;干预后30天、90天、180天和365天的原发性通畅率分别为89%、80%、68%和56%。干预后辅助原发性通畅的平均时间为157±59天;干预后30天、90天、180天和365天的辅助原发性通畅率分别为91%、82%、71%和59%,180天和365天的继发性通畅率分别为97.2%和94.4%。
Cleaner XT旋转血栓切除装置显示出优异的临床和技术成功率,在干预后长达12个月的所有时间点均有良好的通畅结果。